Johnson Investment Counsel’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-26,410
Closed -$836K 636
2019
Q2
$836K Sell
26,410
-1,550
-6% -$46.1K 0.02% 341
2019
Q1
$836K Sell
27,960
-122
-0.4% -$3.5K 0.02% 336
2018
Q4
$867K Sell
28,082
-7,797
-22% -$284K 0.02% 314
2018
Q3
$1.36M Buy
35,879
+1,569
+5% +$59.3K 0.03% 269
2018
Q2
$1.32M Buy
34,310
+7,000
+26% +$236K 0.03% 256
2018
Q1
$920K Buy
27,310
+13,030
+91% +$500K 0.02% 290
2017
Q4
$634K Hold
14,280
0.02% 376
2017
Q3
$715K Hold
14,280
0.02% 326
2017
Q2
$754K Hold
14,280
0.02% 300
2017
Q1
$793K Hold
14,280
0.02% 283
2016
Q4
$743K Buy
+14,280
New +$689K 0.02% 284

Other funds holding PBH

Johnson Investment Counsel's PBH Position: Q3 2019 in Review

Johnson Investment Counsel sold out of Prestige Consumer Healthcare (PBH) in Q3 2019, closing a stake of 26,410 shares — an estimated $836K sold.

Johnson Investment Counsel first reported a position in PBH in Q4 2016 and held it in 11 quarters. The position peaked at $1.36M in Q3 2018. 230 funds tracked by Wall St. Rank hold PBH as of Q3 2019.

  • Johnson Investment Counsel reported no remaining Prestige Consumer Healthcare position as of Q3 2019 after selling out during the quarter.
  • Johnson Investment Counsel sold 26,410 Prestige Consumer Healthcare shares in Q3 2019, an estimated $836K.
  • Johnson Investment Counsel first reported a position in Prestige Consumer Healthcare in Q4 2016 and held it in 11 quarters.
  • Johnson Investment Counsel's Prestige Consumer Healthcare position peaked at $1.36M in Q3 2018.
  • 230 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2019.

Based on Johnson Investment Counsel's 13F filing for Q3 2019, filed 14 Nov 2019.